- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/04 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
Patent holdings for IPC class C07D 213/04
Total number of patents in this class: 233
10-year publication summary
10
|
18
|
14
|
18
|
25
|
14
|
12
|
22
|
12
|
5
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Merck Sharp & Dohme Corp. | 2194 |
6 |
Boehringer Ingelheim International GmbH | 4650 |
6 |
The Johns Hopkins University | 5667 |
6 |
Nocion Therapeutics, Inc. | 42 |
5 |
Novartis AG | 10849 |
4 |
Gentex Corporation | 1890 |
4 |
Hutchison MediPharma Limited | 104 |
4 |
The Procter & Gamble Company | 22017 |
3 |
Canon Inc. | 39888 |
3 |
Dow AgroSciences LLC | 1223 |
3 |
Takeda Pharmaceutical Company Limited | 2713 |
3 |
Vertex Pharmaceuticals Incorporated | 1597 |
3 |
Purdue Research Foundation | 3612 |
3 |
The Cleveland Clinic Foundation | 1572 |
3 |
Dana-Farber Cancer Institute, Inc. | 2571 |
3 |
Rohm and Haas Electronic Materials Korea Ltd. | 330 |
3 |
Shenzhen Chipscreen Biosciences Ltd. | 25 |
3 |
Vanderbilt University | 1901 |
3 |
MSD R & D (China) Co. LTD. | 56 |
3 |
Bristol-myers Squibb Company | 4898 |
2 |
Other owners | 160 |